MLICM
AVNS

Metropolitan Life Insurance Company (MetLife)’s Avanos Medical AVNS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,471
Closed -$49.2K – 218
2024
Q1 		$49.2K Sell
2,471
-438
-15% -$8.47K ﹤0.01% 1414
2023
Q4 		$65.2K Hold
2,909
– – ﹤0.01% 1309
2023
Q3 		$58.8K Buy
2,909
+298
+11% +$6.76K ﹤0.01% 1313
2023
Q2 		$66.7K Hold
2,611
– – ﹤0.01% 1256
2023
Q1 		$77.7K Sell
2,611
-240
-8% -$6.97K ﹤0.01% 1142
2022
Q4 		$77.1K Hold
2,851
– – ﹤0.01% 1211
2022
Q3 		$62.1K Hold
2,851
– – ﹤0.01% 1310
2022
Q2 		$77.9K Sell
2,851
-428
-13% -$12.3K ﹤0.01% 1215
2022
Q1 		$110K Sell
3,279
-10,562
-76% -$340K ﹤0.01% 1136
2021
Q4 		$480K Hold
13,841
– – 0.01% 1463
2021
Q3 		$432K Hold
13,841
– – 0.01% 1563
2021
Q2 		$503K Sell
13,841
-7,484
-35% -$309K 0.01% 1517
2021
Q1 		$933K Buy
21,325
+124
+0.6% +$5.82K 0.01% 986
2020
Q4 		$973K Sell
21,201
-1,399
-6% -$58.2K 0.01% 898
2020
Q3 		$751K Sell
22,600
-823
-4% -$26.3K 0.01% 914
2020
Q2 		$688K Sell
23,423
-3,315
-12% -$96K 0.01% 987
2020
Q1 		$720K Sell
26,738
-693
-3% -$20.7K 0.01% 845
2019
Q4 		$924K Buy
27,431
+134
+0.5% +$4.85K 0.01% 939
2019
Q3 		$1.02M Sell
27,297
-270
-1% -$10.3K 0.02% 845
2019
Q2 		$1.2M Buy
27,567
+200
+0.7% +$8.55K 0.02% 790
2019
Q1 		$1.17M Sell
27,367
-353
-1% -$15.8K 0.02% 801
2018
Q4 		$1.24M Buy
27,720
+339
+1% +$17.8K 0.02% 677
2018
Q3 		$1.88M Buy
27,381
+45
+0.2% +$2.9K 0.03% 561
2018
Q2 		$1.56M Buy
27,336
+113
+0.4% +$5.97K 0.03% 663
2018
Q1 		$1.25M Buy
27,223
+335
+1% +$15.9K 0.02% 792
2017
Q4 		$1.24M Sell
26,888
-46,738
-63% -$2.15M 0.02% 792
2017
Q3 		$3.31M Sell
73,626
-2,212
-3% -$94.4K 0.02% 781
2017
Q2 		$2.98M Buy
75,838
+497
+0.7% +$18.8K 0.02% 825
2017
Q1 		$2.87M Sell
75,341
-116
-0.2% -$4.52K 0.02% 837
2016
Q4 		$2.79M Sell
75,457
-956
-1% -$34.2K 0.02% 851
2016
Q3 		$2.65M Sell
76,413
-53
-0.1% -$1.86K 0.02% 854
2016
Q2 		$2.49M Buy
76,466
+2,544
+3% +$77.9K 0.02% 862
2016
Q1 		$2.12M Buy
73,922
+1,686
+2% +$44.9K 0.02% 879
2015
Q4 		$2.41M Buy
72,236
+170
+0.2% +$5.29K 0.02% 834
2015
Q3 		$2.05M Sell
72,066
-1,031
-1% -$36K 0.01% 904
2015
Q2 		$2.96M Buy
+73,097
New +$3.28M 0.02% 789
2015
Q1 		– Sell
-41,189
Closed -$1.87M – 2232
2014
Q4 		$1.87M Buy
+41,189
New +$1.62M 0.01% 995

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AVNS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 2,471 shares — an estimated $49.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AVNS in Q4 2014 and held it in 37 quarters. The position peaked at $3.31M in Q3 2017. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,471 Avanos Medical shares in Q2 2024, an estimated $49.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Avanos Medical in Q4 2014 and held it in 37 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Avanos Medical position peaked at $3.31M in Q3 2017.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.